Le Lézard
Classified in: Science and technology, Business
Subject: FNC

Bow River Capital's Software Growth Equity Team Makes Majority Platform Investment in HRSoft, a Human Capital Management SaaS Market Leader in Compensation Management


Global HR Tech Company Takes Majority Investment to Drive an Accelerated Build-Out of Its Full Suite of HCM Applications, Continue Scaling Operational Infrastructure, and Profitable Growth

ORLANDO, Fla., Sept. 13, 2022 /PRNewswire/ -- HRSoft announced today that it has selected Bow River Capital's Software Growth Equity (SGE) Team to partner for operational, growth, and innovation expertise. Founded 20+ years ago, HRSoft's SaaS platform is an industry leading low-code platform that empowers enterprises to take control of employee compensation, rewards, and performance management. This modern and market leading system architecture enables the full suite of applications to be 100% configurable and delivered quickly at a significantly lower total cost of ownership versus traditional human capital management systems.

Bow River's SGE team, which has a combined 50+ years investing and operating within the HR tech landscape, recognized the massive opportunity presented by HRSoft's industry-leading compensation software suite and decided to move forward with the majority recapitalization.

David Kennedy, HRSoft's CEO said of the transaction, "The team at HRSoft has done a tremendous job of growing the business and establishing the company as the leading provider of SaaS Compensation Management Software Solutions." David further states, "The HRSoft team has done this with limited access to capital. Now, we're all very enthused to partner with Bow River's Software Growth Equity group. Bow River's major investment in HRSoft, their operational playbook and their team of deeply experienced HR tech veterans will help us rapidly create even greater value for HRSoft's clients, partners, investors, and employees."

As part of the Bow River SGE team's majority-controlled investment, fund managers John Raeder, Maitlan Cramer, and Sean O'Connell have joined HRSoft's Board of Directors.

"We are thrilled to partner with David Kennedy, Tushar Ghoshal, and the entire employee base of HRSoft as we seek to rapidly scale it's market leading low-code architecture and purpose built Compensation Cloud solution," states John Raeder, Managing Director and Head of Software Investments for Bow River Capital's Software Growth Equity strategy. He further states, "through detailed market research and due diligence, we developed strong conviction supporting the Company's mission to optimize the way employers, employees, the extended workforce, and ERP partners align on full compensation lifecycle planning, execution, and compliance."

Bow River Capital Director and SGE team member Maitlan Cramer states, "We have spent significant time investing in the HR Tech industry and have developed a strong investment thesis for a sea of change occurring across the HR function in organizations of all sizes." Cramer further states, "We're thrilled to be working closely with the Company to deploy our SaaS playbook and all our resources in an effort to rapidly build out their software platform, upshift their client success model, and launch a world class go-to-market engine."

CIBC Innovation Banking provided debt financing as a part of the transaction. Holland & Hart LLP served as legal counsel to Bow River Capital on the transaction.

JMP Securities LLC, a Citizens Company served as the exclusive financial advisor and Morgan, Lewis & Bockius LLP served as legal counsel to HRSoft on the transaction.

HRSoft

HRSoft, backed by Bow River Capital's Software Growth Equity Fund, is a market leading employee compensation management software. The flexible low-code solution integrates with any HRIS suite and is enhanced by additional HR solutions: performance management, reward communication and pay equity. The Company rapidly and inexpensively brings products to market, tailors products to meet unique needs of large enterprise clients and minimizes the total cost of ownership. Learn more at www.hrsoft.com or follow the Company on LinkedIn.

Bow River Capital

Bow River Capital is a private alternative asset manager based in Denver, Colorado, focused on investing in the lower middle market in three asset classes, including private equity, real estate, and software growth equity. In addition to its three private fund platforms, the firm launched the Bow River Capital Evergreen Fund (EVERX) in May 2020, which provides institutional-quality private market access to a broader set of investors. Collectively, the Bow River Capital team has deployed capital into diverse industries, asset classes and across the capital structure.

Bow River Capital Evergreen Fund is distributed by Foreside Financial Services, LLC, which is not affiliated with Bow River Capital or its affiliates.

CONTACT: Jane Ingalls, 303-861-8466, [email protected]

SOURCE Bow River Capital


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: